Survival, Graft Atherosclerosis, and Rejection Incidence in Heart Transplant Recipients Treated With Statins: 5-Year Follow-up

Pravastatin therapy offers long-term benefits to heart transplant recipients. It improves 5-year survival, lowers the risk of transplant CAD, and lowers the incidence of hemodynamically significant rejection episodes.